SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Strategies & Market TrendsSpeculating in Takeover Targets


Previous 10 Next 10 
To: richardred who wrote (4286)10/25/2017 9:17:39 AM
From: richardred
   of 6101
 
RE-SHLM speculation- Earnings due today.. IMO a Win Win. If earnings are bad. A sale of the company is needed. If earnings are good. IMO all the more reason for a buyout.

POL-Poly-One PR SNIP>As we look ahead, we will continue to fund our organic growth initiatives as our first priority, seek attractive specialty acquisitions and also be opportunistic with respect to buying back shares."

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: richardred who wrote (4569)10/26/2017 9:20:04 AM
From: richardred
   of 6101
 
A bull-eye in SNAK However a take-under. I even picked a would be acquirer. Hanging onto shares in hopes LNCE might be interested. I'm sure shareholder including myself are not happy about the price. I guess it's better than them having to file chapter 11.

Inventure Foods, Inc. to be Acquired by Utz Quality Foods, LLC

GlobeNewswireOctober 26, 2017

PHOENIX and HANOVER, Pa., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Inventure Foods, Inc. ( SNAK) (“Inventure Foods” or the “Company”), a leading specialty food marketer and manufacturer, and Utz Quality Foods, LLC (“Utz”), the largest privately-held and family-managed branded salty snack manufacturer and marketer in the United States, today announced they entered into a merger agreement pursuant to which Utz has agreed to acquire all of the Company’s outstanding shares of common stock in an all-cash transaction.

Under the terms of the merger agreement, an indirect subsidiary of Utz will commence a tender offer to acquire all of the outstanding shares of the Company’s common stock at a price of $4.00 per share in cash, for a total purchase price of approximately $165 million, including the assumption of approximately $75 million of debt and debt-like items, net of cash, approximately $8 million of the Company’s estimated closing costs and approximately $3 million due to equity award holders. The acquisition is structured as an all-cash tender offer for all of the outstanding shares of Inventure Foods common stock, to be followed by a merger in which each remaining untendered share of Inventure Foods will be converted into the right to receive the same $4.00 per share cash price paid in the tender offer.

The transaction, which was unanimously approved by the Boards of both Inventure Foods and Utz, is subject to the tender of more than 50 percent of the fully diluted shares of Inventure Foods common stock, the receipt of certain regulatory approvals and other customary closing conditions. The transaction is not subject to a financing contingency and is expected to close by the end of the fourth quarter of 2017. The tender offer is expected to commence within ten business days.

“This transaction is the result of diligent analysis and thoughtful strategic deliberations by our Board of Directors and the result of the strategic and financial review we initiated in July 2016,” stated Terry McDaniel, Chief Executive Officer of Inventure Foods. “Our Board, with the advice of independent advisors, determined that this transaction will deliver immediate and certain cash value to our stockholders and new opportunities for our snack brands.”

“We are tremendously excited about the opportunity to acquire Inventure Foods,” said Dylan Lissette, Chief Executive Officer of Utz Quality Foods. “The Company’s specialty snack food products and brands, as well as its geographic footprint, customer relationships and distribution strengths, are highly complementary to our business and we look forward to continuing Inventure’s strong heritage of innovation in both healthy and indulgent snacking. We have also been extremely impressed with the team at Inventure, and look forward to working together going forward.”

As previously announced, on September 29, 2017, the Company entered into a Limited Waiver and Sixth Amendment to Credit Agreement (the “Sixth Amendment”) with BSP Agency, LLC, as agent (“BSP”), and the lenders (the “Lenders”) from time to time a party to the Credit Agreement (defined below), which further amended the Credit Agreement, dated as of November 18, 2015, among the Borrowers a party thereto, the Lenders, and BSP (as amended from time to time, the “Credit Agreement”). Under the terms of the Sixth Amendment, the Lenders agreed to, among other things, (i) a further extension from September 30, 2017 to October 31, 2017 of the temporary waiver of the requirement under the Credit Agreement to deliver audited financial statements without a going concern opinion, and (ii) a temporary waiver until October 31, 2017 of the financial covenants with which the Company was required to comply under the Credit Agreement.

As a result of this transaction, BSP and the other Lenders have agreed to further extend the temporary waivers from October 31, 2017 to January 15, 2018 pursuant to a Limited Waiver, Consent and Seventh Amendment to Credit Agreement (the “Seventh Amendment”), in order to give the Company sufficient time to complete the proposed transaction. Without this further extension of the temporary waivers beyond October 31st, the Company would have been in default of the EBITDA financial covenants under the Credit Agreement and the requirement to deliver audited financial statements without a going concern opinion. Pursuant to the Seventh Amendment, the Lenders have agreed to loan the Company up to an additional $5 million, which the Company may require to satisfy its expected operating expenses through December 31, 2017.

finance.yahoo.com


Share RecommendKeepReplyMark as Last ReadRead Replies (2)


From: richardred10/27/2017 8:32:19 AM
   of 6101
 
CVS makes more than $66 billion bid for Aetna: sources

reuters.com

Share RecommendKeepReplyMark as Last Read


From: richardred10/30/2017 9:04:21 AM
   of 6101
 
Merger Monday!

Akzo Nobel Confirms $30B Merger Talks With Axalta
investopedia.com


Share RecommendKeepReplyMark as Last Read


To: richardred who wrote (3100)10/30/2017 1:45:27 PM
From: richardred
   of 6101
 
LyondellBasell Makes Takeover Approach to Braskem Talks are at an early stage for Brazilian company with market value of $11.4 billion.

wsj.com

Share RecommendKeepReplyMark as Last Read


To: richardred who wrote (4596)11/1/2017 10:46:06 AM
From: The Ox
   of 6101
 
ACET down 15% in past 2 weeks heading into earnings...doesn't instill confidence for a rebound at the moment (unlike the IPXL news which saw the stock soar into the take out).


Share RecommendKeepReplyMark as Last ReadRead Replies (2)


To: The Ox who wrote (4609)11/1/2017 12:34:49 PM
From: richardred
1 Recommendation   of 6101
 
I'm not expecting anything , but negative on the earnings release tomorrow. Today's action kind of implies that. I still see value here. This company will be in transition. There's a new CEO. A pharma guy. The current CFO will also be leaving here to. I've been doing a little bit of homework here. The sum of what the company paid just to enter the generic business is worth more than the total market cap. of just of 300 million. Bearing in mind I'm speculating. I think this make a good case for separating performance chemicals from generics. This leading to a stronger stock price in due time. Although painful short term. I can hold this one and dollar cost average because it does pay a dividend . IMO it's not overpriced to forward earnings. The Near term appeal might be separating into two companies. IMO the company stumbled on their last acquisition. However I believe the company also acquired a good pipeline of generics waiting for future approval.

P.S. Tomorrow could be a chance for a big drop with lag to follow. PRGO is selling now at less than half what MYLN offered. I couldn't believe at the time they rejected the offer.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: richardred who wrote (4605)11/1/2017 1:45:19 PM
From: richardred
   of 6101
 
RE-SNAK Maybe A lesson learned from my last attempt. I'll pass on this one. I've looked at PBI recently before today's drop. Pitney leveraged up with last acquisition. IMO I see the dividend going away to.

Pitney Bowes to Explore Strategic Alternatives

Shipping-services firm hurt by lower mail volume.

wsj.com

Share RecommendKeepReplyMark as Last Read


From: Glenn Petersen11/2/2017 10:01:41 AM
   of 6101
 
Potential acquisition candidates for Amazon in the prescription drug space:

Message 31331554

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: richardred who wrote (4604)11/2/2017 10:14:16 AM
From: richardred
   of 6101
 
Sold out last Batch of SHLM call options for giant % gain.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)
Previous 10 Next 10